Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
暂无分享,去创建一个
I. Shimomura | M. Koga | S. Kasayama | Daisuke Tamada | M. Otsuki | S. Morita | K. Mukai | Tetsuhiro Kitamura | Yukiko Tabuchi
[1] V. Guarnotta,et al. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? , 2014, European journal of endocrinology.
[2] S. Kihara,et al. The elderly. , 2014, Journal of atherosclerosis and thrombosis.
[3] Malcolm D. Smith,et al. Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study. , 2012, Rheumatology.
[4] T. Sanke,et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values , 2012, Diabetology International.
[5] T. Yoshimoto,et al. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment , 2011, Hypertension Research.
[6] P. Frith,et al. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. , 2011, The Journal of clinical endocrinology and metabolism.
[7] T. Ogihara,et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) , 2009, Hypertension Research.
[8] T. Ogihara,et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2 , 2009, Hypertension Research.
[9] G. Arnaldi,et al. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines , 2004, Clinical endocrinology.
[10] C. Bhagat. Diagnosis and Complications of Cushing's Syndrome: a Consensus Statement. , 2004 .
[11] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[12] A Sekikawa,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.
[13] J. Etxabe,et al. Morbidity and mortality in Cushing's disease: an epidemiological approach , 1994, Clinical endocrinology.
[14] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[15] H. Segal,et al. Glucocorticoid control of the liver glycogen synthetase-activating system. , 1969, The Journal of biological chemistry.
[16] D. Orth.,et al. THE ADRENAL CORTEX , 1948 .
[17] K. Shimamoto. The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) , 2014 .
[18] N. Krone,et al. CHAPTER 15 – The Adrenal Cortex , 2011 .
[20] L. Mandarino,et al. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.